Production (Stage)
Stoke Therapeutics, Inc.
STOK
$9.43
$0.252.72%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 357.32M | 216.90M | 239.20M | 281.98M | 178.58M |
Total Receivables | 606.00K | 700.00K | 691.00K | 305.00K | 11.00K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 12.69M | 11.12M | 9.84M | 10.35M | 10.72M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 5.11M | 4.04M | 3.88M | 4.36M | 3.96M |
Total Current Assets | 375.74M | 232.76M | 253.61M | 296.99M | 193.28M |
|
|||||
Total Current Assets | 375.74M | 232.76M | 253.61M | 296.99M | 193.28M |
Net Property, Plant & Equipment | 7.44M | 8.25M | 9.26M | 10.27M | 11.34M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 721.00K | 721.00K | 494.00K | 494.00K | 569.00K |
Total Assets | 406.89M | 271.56M | 293.32M | 307.76M | 205.18M |
|
|||||
Total Accounts Payable | 2.19M | 2.50M | 2.49M | 3.95M | 2.10M |
Total Accrued Expenses | 19.91M | 15.49M | 12.87M | 11.19M | 9.38M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.35M | 2.32M | 2.30M | 2.28M | 2.21M |
Total Finance Division Other Current Liabilities | 20.24M | 19.74M | 32.21M | 27.09M | 21.90M |
Total Other Current Liabilities | 20.24M | 19.74M | 32.21M | 27.09M | 21.90M |
Total Current Liabilities | 44.69M | 40.06M | 49.87M | 44.50M | 35.59M |
|
|||||
Total Current Liabilities | 44.69M | 40.06M | 49.87M | 44.50M | 35.59M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 1.86M | 2.45M | 3.01M | 3.55M | 4.13M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 10.27M | 26.00K | 8.33M | 17.00M | 25.13M |
Total Liabilities | 56.81M | 42.53M | 61.21M | 65.05M | 64.84M |
|
|||||
Common Stock & APIC | 728.13M | 720.00M | 712.30M | 696.64M | 568.57M |
Retained Earnings | -377.95M | -490.83M | -480.35M | -453.92M | -428.22M |
Treasury Stock & Other | -104.00K | -151.00K | 166.00K | -15.00K | -- |
Total Common Equity | 350.07M | 229.02M | 232.11M | 242.71M | 140.34M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 350.07M | 229.02M | 232.11M | 242.71M | 140.34M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 350.07M | 229.02M | 232.11M | 242.71M | 140.34M |
|